Verano Holdings (VRNO) Capital Expenditures (QoQ) (2021 - 2026)
Verano Holdings (VRNO) Capital Expenditures (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Verano Holdings | 439.55 Mn | 354.35 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.53% |
| Mar 31, 2026 | 58.33% |
| Dec 31, 2025 | 26.48% |
| Sep 30, 2025 | -28.75% |
| Jun 30, 2025 | -24.49% |
| Mar 31, 2025 | -2.67% |
| Dec 31, 2024 | -74.83% |
| Sep 30, 2024 | 205.62% |
| Jun 30, 2024 | 90.91% |
| Mar 31, 2024 | 144.93% |
| Dec 31, 2023 | -316.69% |
| Sep 30, 2023 | 24.74% |
| Jun 30, 2023 | -6.65% |
| Mar 31, 2023 | 108.25% |
| Dec 31, 2022 | -197.45% |
| Sep 30, 2022 | 336.48% |
| Jun 30, 2022 | -193.18% |
| Mar 31, 2022 | -2.05% |
| Dec 31, 2021 | 63.47% |